No Detail Found!

Construction of a disulfidptosis-associated lncRNAs risk model to predict prognosis and immuno-infiltration analysis of lung adenocarcinoma

Author(s)
Jiaming Liu Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Hao Nie Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Wenji Du Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
Wei Song Yuexiu District, Guangzhou, Guangdong Province, 510405,China; Department of Endocrinology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510405, China.
Abstract
Objective: To develop a risk model based on LncRNAs associated with disulfidptosis to forecast the prognosis and assess immune infiltration of Lung adenocarcinoma (LUAD). Methods: This study employed a bioinformatics approach. The study was conducted from March 29, 2023 and concluded on July 1, 2023 at Guangzhou University of Chinese Medicine, Guangzhou, China. Transcriptomic data specific to LUAD were collected from TCGA database. Disulfidptosis-related LncRNAs were preliminarily screened using co-expression analysis, followed by screening using Lasso regression and Cox regression to identify LncRNAs. Subsequently, prognostic prediction models were constructed. To assess the model, survival analysis, subject operating characteristic curves, and calibration curves were employed. To evaluate the tumor microenvironment, the “estimate” package was used, while the “ggpubr” package was utilized to visualize the variations. Additionally, we employed CIBERSORT to examine immune cell infiltration abundance. Results: A prognostic prediction model was constructed using five LncRNAs. The high-risk group displayed a shorter overall survival and progression-free survival (P<0.05). The concordance index was calculated as 0.704 (95% CI: 0.6540.754). GSEA analysis reveals that high risk group is associated with the cell cycle pathway and steroid hormone biosynthesis pathway, while the low-risk group is associated with hematopoietic cell pathway and allograft rejection pathway. Immune cell infiltration analysis indicated associations between the prognostic model and activated T cells CD4 memory, T cells CD8, etc. Conclusions: The risk model of Disulfidptosis-related LncRNAs can predict the prognosis of LUAD and evaluate the immune infiltration, providing a new direction for the treatment of LUAD.
Publication Details
Page(s) 2368-2372
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 10, Year: 2024

Request the full text from PASTIC

Keywords
Lung Adenocarcinoma, long non-coding RNAs, Disulfidptosis
References
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Cancer J Clin A,Zhang Z,Zhang Y,Su J,P. J .2023 .Analysis of factors affecting intraoperative conversion from thoracoscopic radical resection of lung cancer to thoracotomy and intraoperative management experience. Pak J Med Sci, 10(5) : 7422-1393.
Thai AA,Solomon BJ,Sequist LV,Gainor JF,Heist RS,Bade BC,Dela CC .2019 .Lung cancer. Clin Chest Med, 10(1) : 1-24.
Chen B,Yan X,Wang X,Mao Y. .2023 .Effectiveness of precise and quantitative rapid pulmonary rehabilitation nursing program for elderly patients with lung cancer during the perioperative period: A randomized controlled trial. Pak J Med Sci, 10(2) : 7103-577.
Zheng T,Liu Q,Xing F,Zeng C,Wang W. Disulfidptosis C .2023 .: a new form of programmed cell death. J Exp Clin Cancer Res, 10(1) : 137.
Liu X,Nie L,Zhang Y,Yan Y,Wang C,Colic M .2023 .Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol, 10(3) : 404-414.
Zheng P,Zhou C,Ding Y,Duan S Y .2023 .Disulfidptosis: a new target for metabolic cancer therapy. J Exp Clin Cancer Res, 10(1) : 103.
Kopp F,Mendell JT .2018 .Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell, 01(3) : 393-407.
Lu S,Shan N,Chen X,Peng F,Wang Y,Long H Y .2021 .A novel immunerelated long non-coding RNAs risk model for prognosis assessment of lung adenocarcinoma. Aging (Albany NY), 10(23) : 25550-25563.
Tang Y,Li C,Zhang YJ,Wu ZH .2021 .Ferroptosis-Related Long NonCoding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma. Int J Biol Sci, 10(3) : 702-711.
Liu X,Nie L,Zhang Y,Yan Y,Wang C,Colic M .2023 .Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol, 10(3) : 404-414.
Zheng T,Liu Q,Xing F,Zeng C,Wang W. Disulfidptosis C .2023 .: a new form of programmed cell death. J Exp Clin Cancer Res, 10(1) : 137.
Yang L,Liu J,Li S,Liu X,Zheng F,Xu S .2023 .Based on disulfidptosis, revealing the prognostic and immunological characteristics of renal cell carcinoma with tumor thrombus of vena cava and identifying potential therapeutic target AJAP1. J Cancer Res Clin Oncol, 10(12) : 9787-9804.
Zhao G,Jiang Y,Wang Y,Wang S,Li N. .2023 .Comprehensive characterization of cell disulfidptosis in human cancers: An integrated pan-cancer analysis. Genes Dis, 10(4) : 101095.
Das PK,Siddika A,Rashel KM,Auwal A,Soha K,Rahman MA .2023 .Roles of long noncoding RNA in triple-negative breast cancer. Cancer Med, : .
Tang B,Hu L,Jiang T,Li Y,Xu H,Zhou H .2022 .A MetabolismRelated Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma. Int J Mol Sci, 10(20) : .
Ma C,Li F,Gu Z,Yang Y,Qi Y. .2023 .A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma. Front Pharmacol, 10 : 1146840.
Jiang K,Wu L,Yin X,Tang Q,Yin J,Zhou Z .2022 .Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer. Front Genet, 10 : 1036098.
0

Citations

0

Downloads

185

Views